Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs).

Adrian R, Martineau,; Beverley D, MacLaughlin,; Richard L, Hooper,; Neil C, Barnes,; David A, Jolliffe,; Claire L, Greiller,; Kate, Kilpin,; David, McLaughlin,; Gareth, Fletcher,; Charles A, Mein,; Mimoza, Hoti,; Robert, Walton,; Jonathan, Grigg,; Peter M, Timms,; Raj K, Rajakulasingam,; Angshu, Bhowmik,; Marion, Rowe,; Timothy R, Venton,; Aklak B, Choudhury,; David E, Simcock,; Zia, Sadique,; William R, Monteiro,; Christopher J, Corrigan,; Catherine M, Hawrylowicz,; Christopher J, Griffiths,

doi:10.1136/thoraxjnl-2014-206449

Public

Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs).

Published in Thorax • May 1, 2015

Authors:

Martineau, Adrian R

MacLaughlin, Beverley D

Hooper, Richard L

Abstract

RATIONALE: Asthma exacerbations are commonly precipitated by viral upper respiratory infections (URIs). Vitamin D insufficiency associates with susceptibility to URI in patients with asthma. Trials of vitamin D in adults with asthma with incidence of exacerbation and URI as primary outcome are lacki...

Subject

Asthma

Respiratory Infection

Viral infection

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!